Skip to search formSkip to main contentSkip to account menu

Losartan Potassium

Known as: 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, Monopotassium Salt, Monopotassium Salt, Losartan, Salt, Losartan Monopotassium 
The potassium salt of losartan, a non-peptide angiotensin II receptor antagonist with antihypertensive activity. Losartan selectively and… 
National Institutes of Health

Related topics

Related topics

21 relations
Angiotensin 2 Receptor Antagonists [MoA]Angiotensin 2 Type 1 Receptor Antagonists [MoA]Congestive heart failureDecreased Blood Pressure [PE]

Broader (4)

Biphenyl CompoundsImidazolesLosartanTetrazoles

Narrower (4)

CozaarDuP-753HyzaarMK-954

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
HPLC-PDA Determination of Losartan Potassium and Hydrochlorothiazide Using Design of Experiments
A simple, rapid, precise, accurate, sensitive and stability indicating high performance liquid chromatographic method has been… 
2013
2013
FORMULATION AND IN VITRO EVALUATION OF LOSARTAN POTASSIUM MUCOADHESIVE BUCCAL TABLETS
Objective: The Losartan potassium mucoadhesive buccal tablet were prepared using mucoadhesive polymers such as Carbopol 940P… 
2013
2013
FLOATING MATRIX TABLET OF LOSARTAN POTASSIUM BY USING HYDROPHILIC SWELLING POLYMER AND NATURAL GUM
The main purpose of this study was to prepare the losartan potassium controlled release floating tablets by using effervescent… 
2010
2010
A NOVEL DRUG-DRUG SOLID DISPERSION OF HYDROCHLOROTHIAZIDE- LOSARTAN POTASSIUM
To investigate the effect of a novel drugdrug sol id dispersion approach on the dissolution of hydrochlorothiazide in a fixed… 
2009
2009
IN VITRO EVIDENCES FOR SIMVASTATIN AND LOSARTAN POTASSIUM INTERACTION AND ITS IN VIVO IMPLICATIONS
ABSTRACT In the present paper, we describe the in vitro availability of simvastatin, a potent HMG-CoA reductase inhibitor, in… 
2009
2009
Losartan Metabolite EXP 3179 An AT 1-Receptor – Independent Treatment Strategy for Patients With the Metabolic Syndrome ?
Losartan potassium, the first orally active nonpeptide angiotensin receptor blocker (ARB) to be introduced for clinical use in… 
2006
2006
In vitro availability of atorvastatin in presence of losartan.
Hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) are a group of cholesterol lowering agents that have become the… 
2006
2006
Bioequivalence Study of Two Losartan Formulations Administered Orally in Healthy Male Volunteers
Summary The bioavailability of a new losartan preparation (2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]imidazole-5… 
2005
2005
Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil
Objective:  To retrospectively investigate elevation of serum potassium when spironolactone (25 or 50 mg/day) and furosemide were… 
2003
2003
Simultaneous spectrophotometric determination of losartan potassium and hydrochlorothiazide in tablets
Two simple, accurate and precise methods for simultaneous estimation of losartan potassium and hydrochlorothiazide in combined… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)